You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18-147

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Proteinuric Kidney Disease Trial in United States (VX-147, Placebo)

Recruiting
  • Proteinuric Kidney Disease
  • Huntsville, Alabama
  • +27 more
Jun 29, 2022

Hemophilia A, Hemophilia B Trial in Worldwide (Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US), Haemophilia

Not yet recruiting
  • Hemophilia A
  • Hemophilia B
  • Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)
  • Haemophilia Joint Health Score (HJHS)
  • Sofia, Bulgaria
  • +55 more
May 3, 2023

Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
Jul 13, 2023

Condylomata Acuminata, Papillomavirus Infections, Skin Diseases, Viral Trial in United States (VP-102 and applicator, Placebo)

Completed
Has Results
  • Condylomata Acuminata
  • +7 more
  • VP-102 and applicator
  • Placebo
  • Plainfield, Indiana
  • +3 more
Aug 27, 2021

Glomerulosclerosis, Focal Segmental Trial in Worldwide (VX-147)

Completed
  • Glomerulosclerosis, Focal Segmental
  • Birmingham, Alabama
  • +43 more
Nov 10, 2022

Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
Nov 3, 2022

Pulmonary Arterial Hypertension Trial in Cincinnati (Sotatercept)

Recruiting
  • Pulmonary Arterial Hypertension
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center ( Site 1602)
Jan 31, 2023

Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:

Completed
  • Type 2 Diabetes
  • Nephropathy
  • MK0954, losartan / Duration of Treatment: mean 3.4 years
  • Placebo / Duration of Treatment: mean 3.4 years
  • (no location specified)
Feb 7, 2022

Carotid Stenosis, Cognitive Impairment, Hyperbaric Oxygen Therapy Trial (procedure, drug, behavioral)

Not yet recruiting
  • Carotid Stenosis
  • +3 more
  • Hyperbaric oxygen therapy
  • +2 more
  • (no location specified)
Aug 6, 2023

Temporomandibular Joint Dysfunction Syndrome, Forward Head Posture Trial in Mersin (Exercises)

Completed
  • Temporomandibular Joint Dysfunction Syndrome
  • Forward Head Posture
  • Exercises
  • Mersin, Lefkosa, Turkey
    Cyprus International University
Jul 31, 2023

Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body

Not yet recruiting
  • Pancreas Cancer
  • +2 more
  • Stereotactic Ablative Body Radiation (SABR)
  • Tumor Treating Fields (TTF)
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022

Cold Symptom Trial in Ferrara (DefensePlus, Placebo)

Recruiting
  • Cold Symptom
  • DefensePlus
  • Placebo
  • Ferrara, Italy
    Azienda Ospedaliero Universitaria di Ferrara
Jan 13, 2023

Gut Microbiota in Epilepsy Following Ketogenic Diet

Recruiting
  • Epilepsy
    • Athens, Haidari, Greece
      Attikon Athens University Hospital
    Jun 1, 2023

    Stage III Oropharyngeal Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Oropharyngeal

    Active, not recruiting
    Has Results
    • Stage III Oropharyngeal Squamous Cell Carcinoma
    • +4 more
    • Birmingham, Alabama
    • +221 more
    Sep 7, 2022

    Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • La Jolla, California
    • +159 more
    Jan 23, 2023

    Depression Trial in Jyväskylä, Tampere (Flow with Nature)

    Completed
    • Depression
    • Flow with Nature
    • Jyväskylä, Finland
    • +2 more
    Jun 28, 2021

    Quality of Life of Bone Tumor of Lower Limbs Treated With

    Enrolling by invitation
    • Sarcoma, Ewing
    • +2 more
      • Bologna, Italy
        Istituto Ortopedico Rizzoli
      Mar 17, 2023

      Relapsed or Refractory Follicular Lymphoma With Enhancer of

      Recruiting
      • Lymphoma, Follicular
      • Anjo-shi, Aichi, Japan
      • +174 more
      Dec 12, 2022

      Healthy, Nutritional and Metabolic Diseases Trial in México (Dietary Supplement: A package containing a mix of functional foods)

      Not yet recruiting
      • Healthy
      • Nutritional and Metabolic Diseases
      • Dietary Supplement: A package containing a mix of functional foods
      • México, Mexico City, Mexico
        Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
      Feb 1, 2023

      Hypospadias Trial

      Not yet recruiting
      • Hypospadias
        • (no location specified)
        Oct 4, 2022

        Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Percutaneous Coronary Intervention Trial in Falls Church

        Terminated
        Has Results
        • Diabetes Mellitus, Type 2
        • +2 more
        • Falls Church, Virginia
          Inova Fairfax Hospital
        Dec 22, 2022

        Apophysitis; Juvenile Trial in United States (Dexamethasone Sodium Phosphate, Iontophoresis, Physical Therapy)

        Suspended
        • Apophysitis; Juvenile
        • Dexamethasone Sodium Phosphate
        • +2 more
        • Chesapeake, Virginia
        • +4 more
        Mar 8, 2022

        Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants

        Active, not recruiting
        • Acute Myeloid Leukemia (AML)
          • Moscow, Moskva, Russian Federation
          • +9 more
          Jan 27, 2022

          Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

          Active, not recruiting
          • Melanoma
          • +2 more
          • 124I-Humanized 3F8
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Dec 1, 2022

          Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (5 µmol/kg), Placebo)

          Terminated
          Has Results
          • Colorectal Cancer
          • Chemotherapy-induced Peripheral Neuropathy
          • Calmangafodipir (5 µmol/kg)
          • Placebo
          • Aalst, Belgium
          • +64 more
          Nov 19, 2021